BACKGROUND: Critical limb ischemia (CLI) caused by peripheral arterial disease is associated with significant morbidity and mortality. This condition is associated with a 30 % amputation rate as well as mortality levels which might be as high as 25 %. There is no pharmacological therapy available, but several reports have suggested that mesenchymal stem cells (MSCs) may be a useful therapeutic option. METHODS: This study, done at a university hospital, evaluated 13 patients for a phase I trial to investigate the safety and efficacy of intra-arterial MSCs in CLI patients. Eight patients with ten affected limbs were recruited for the study. As two patients (three limbs) died of ischemic cardiac events during the 6-month follow-up period, seven limbs were finally evaluated for the study. RESULTS: There was significant pain relief. Visual analog scale (VAS) scores decreased from 2.29 ± 0.29 to 0.5 ± 0.34 (p < 0.05), ankle brachial pressure index (ABPI) increased significantly from 0.56 ± 0.02 to 0.67 ± 0.021 (p < 0.01), and transcutaneous oxygen pressure (TcPO2) also increased significantly in the foot from 13.57 ± 3.63 to 38 ± 3.47. Similar improvement was seen in the leg as well as the thigh. There was 86 % limb salvage and six of seven ulcers showed complete or partial healing. CONCLUSION: It was concluded that intra-arterial MSCs could be safely administered to patients with CLI and was associated with significant therapeutic benefits.
BACKGROUND:Critical limb ischemia (CLI) caused by peripheral arterial disease is associated with significant morbidity and mortality. This condition is associated with a 30 % amputation rate as well as mortality levels which might be as high as 25 %. There is no pharmacological therapy available, but several reports have suggested that mesenchymal stem cells (MSCs) may be a useful therapeutic option. METHODS: This study, done at a university hospital, evaluated 13 patients for a phase I trial to investigate the safety and efficacy of intra-arterial MSCs in CLI patients. Eight patients with ten affected limbs were recruited for the study. As two patients (three limbs) died of ischemic cardiac events during the 6-month follow-up period, seven limbs were finally evaluated for the study. RESULTS: There was significant pain relief. Visual analog scale (VAS) scores decreased from 2.29 ± 0.29 to 0.5 ± 0.34 (p < 0.05), ankle brachial pressure index (ABPI) increased significantly from 0.56 ± 0.02 to 0.67 ± 0.021 (p < 0.01), and transcutaneous oxygen pressure (TcPO2) also increased significantly in the foot from 13.57 ± 3.63 to 38 ± 3.47. Similar improvement was seen in the leg as well as the thigh. There was 86 % limb salvage and six of seven ulcers showed complete or partial healing. CONCLUSION: It was concluded that intra-arterial MSCs could be safely administered to patients with CLI and was associated with significant therapeutic benefits.
Authors: Michael P Murphy; Jeffrey H Lawson; Brian M Rapp; Michael C Dalsing; Janet Klein; Michael G Wilson; Gary D Hutchins; Keith L March Journal: J Vasc Surg Date: 2011-04-22 Impact factor: 4.268
Authors: Mark D Iafrati; John W Hallett; George Geils; Gregory Pearl; Alan Lumsden; Eric Peden; Dennis Bandyk; K S Vijayaraghava; R Radhakrishnan; Enrico Ascher; Anil Hingorani; Sean Roddy Journal: J Vasc Surg Date: 2011-10-21 Impact factor: 4.268
Authors: Dirk H Walter; Hans Krankenberg; Jörn O Balzer; Christoph Kalka; Iris Baumgartner; Michael Schlüter; Torsten Tonn; Florian Seeger; Stefanie Dimmeler; Edelgard Lindhoff-Last; Andreas M Zeiher Journal: Circ Cardiovasc Interv Date: 2011-01-04 Impact factor: 6.546
Authors: R B Van Tongeren; J F Hamming; W E Fibbe; V Van Weel; S J G C Frerichs; A M Stiggelbout; J H Van Bockel; J H Lindeman Journal: J Cardiovasc Surg (Torino) Date: 2008-02 Impact factor: 1.888
Authors: C Kalka; H Masuda; T Takahashi; W M Kalka-Moll; M Silver; M Kearney; T Li; J M Isner; T Asahara Journal: Proc Natl Acad Sci U S A Date: 2000-03-28 Impact factor: 11.205
Authors: S Fadilah Abdul Wahid; Nor Azimah Ismail; Wan Fariza Wan Jamaludin; Nor Asiah Muhamad; Muhammad Khairul Azaham Abdul Hamid; Hanafiah Harunarashid; Nai Ming Lai Journal: Cochrane Database Syst Rev Date: 2018-08-29
Authors: Michael H Carstens; Francisco J Quintana; Santos T Calderwood; Juan P Sevilla; Arlen B Ríos; Carlos M Rivera; Dorian W Calero; María L Zelaya; Nelson Garcia; Kenneth A Bertram; Joseph Rigdon; Severiano Dos-Anjos; Diego Correa Journal: Stem Cells Transl Med Date: 2021-04-07 Impact factor: 6.940